Chloraseptic

Chloraseptic is a prominent manufacturer of sore throat relief products, including lozenges and sprays, providing effective solutions for throat discomfort due to colds and allergies. Chloraseptic specializes in over-the-counter healthcare products focused on sore throat relief. In September 2000, the company was acquired by Prestige Consumer Healthcare, Inc. from Procter & Gamble, although financial terms were not disclosed.

The company is headquartered in Lynchburg, US. Chloraseptic® is primarily known for its fast-acting sore throat relief products, which include a range of lozenges and sprays designed to alleviate throat pain and discomfort. The core product offerings consist of Cherry Spray, MAX Wild Berries Lozenges, Wild Berries Spray, Menthol Spray, and Cherry Lozenges, all formulated to provide targeted relief from sore throat symptoms. These products are typically used by individuals experiencing throat irritation due to colds, flu, or allergies, thus addressing a significant consumer need in the over-the-counter healthcare market.

Chloraseptic® products are sold across various geographical markets, including the United States and select international regions, catering to both retail customers and consumers seeking immediate relief from throat discomfort. Chloraseptic® operates through a multi-faceted revenue model that includes direct-to-consumer sales as well as partnerships with retailers and wholesalers. This structure allows the company to effectively reach a broad customer base, from individual consumers purchasing products at pharmacies and supermarkets to larger retail chains stocking their offerings. The flagship products, namely the various sprays and lozenges, are priced competitively to ensure accessibility while delivering effective sore throat relief.

Transactions typically occur at retail locations, where consumers directly purchase products, thereby generating immediate sales revenue for the company. This approach positions Chloraseptic® as a leading brand in the sore throat relief category, leveraging established distribution channels to maximize market penetration. Chloraseptic plans to leverage recent acquisitions to enhance its product line and expand its geographic reach. Following its acquisition by Prestige Consumer Healthcare, Inc.

in September 2000, the company aims to introduce new products to address varying consumer needs in sore throat relief. Additionally, Chloraseptic is exploring opportunities to penetrate international markets to increase its customer base. Recent funding will be directed towards research and development for new product formulations and expanding distribution channels into targeted regions.